3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
13
Recruiting
8
Unknown
3
Not yet recruiting
3
Active not recruiting
3
Withdrawn
1
Terminated
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
58
Neoplasms
52
Colorectal Neoplasms
32
Prostatic Neoplasms
29
Lung Neoplasms
21
Stomach Neoplasms
17
Carcinoma, Non-Small-Cell Lung
16
Carcinoma, Hepatocellular
16
Uterine Cervical Neoplasms
13
Anxiety Disorders
13
Colonic Neoplasms
11
Brain Neoplasms
11
Pancreatic Neoplasms
10
Lymphoma, Follicular
9
Leukemia, Myeloid, Acute
8
Head and Neck Neoplasms
8
Barrett Esophagus
8
Urinary Bladder Neoplasms
7
Rectal Neoplasms
7
Esophageal Squamous Cell Carcinoma
7
Esophageal Neoplasms
7
Disease
7
Diabetes Mellitus
7
Cholangiocarcinoma
7
Sarcoma
6
Recurrence
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Pain
6
Ovarian Neoplasms
6
Motor Activity
6
Interventions
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
OTHER
×
Intermittent Fasting
×
Clear all
NCT06645093
2026-03-10
FasteStudien
University of Oslo
Phase NA
Enrolling by invitation
40 enrolled